Abstract
The population of influenza virus consists of a huge variety of variants, called quasispecies, due to error-prone replication. Previously, we reported that progeny virions of influenza virus become infected to adjacent cells via cell-to-cell transmission pathway in the presence of oseltamivir. During cell-to-cell transmission, viruses become infected to adjacent cells at high multiplicity since progeny virions are enriched on plasma membrane between infected cells and their adjacent cells. Co-infection with viral variants may rescue recessive mutations with each other. Thus, it is assumed that the cell-to-cell transmission causes expansion of virus quasispecies. Here, we have demonstrated that temperature-sensitive mutations remain in progeny viruses even at non-permissive temperature by co-infection in the presence of oseltamivir. This is possibly due to a multiplex infection through the cell-to-cell transmission by the addition of oseltamivir. Further, by the addition of oseltamivir, the number of missense mutation introduced by error-prone replication in segment 8 encoding NS1 was increased in a passage-dependent manner. The number of missense mutation in segment 5 encoding NP was not changed significantly, whereas silent mutation was increased. Taken together, we propose that oseltamivir expands influenza virus quasispecies via cell-to-cell transmission and may facilitate the viral evolution and adaptation.
Similar content being viewed by others
Introduction
RNA viruses exist as genetically diverse populations, termed quasispecies, due to error-prone replication by viral RNA-dependent RNA polymerases1,2,3. Although the high mutation rate carries a substantial risk of production of defective progeny viruses, the expansion of virus quasispecies is a great opportunity for viruses to evolve and escape from antiviral drugs4,5,6,7,8, neutralizing antibody9 and cytotoxic T-cell10,11. It is also reported that virus quasispecies are associated with pathogenesis such as central nervous system infection of poliovirus12,13. Mathematical models predicted that virus quasispecies are not just collection of different kind of mutants, but a group of interactive variants, which contribute to the characteristics of the population together14.
Influenza virus is one of the most serious zoonotic pathogens causing seasonal epidemics and periodic pandemics among human beings around the world. The genome of influenza virus consists of eight-segmented and single-stranded RNAs. The segmented structure of the virus genome allows genetic reassortment when more than two genetically different viruses co-infect a single cell. The viral envelope consists of a lipid bilayer derived from cellular plasma membrane with two viral spike proteins, hemagglutinin (HA) and neuraminidase (NA). Influenza virus infection is initiated by the attachment of HA on virus particles to terminal sialic acid residues in glycoconjugates15. NA possesses the enzymatic activity that cleaves α-ketosidic linkages between terminal sialic acids and adjacent sugar residues16. In the absence of the functional sialidase activity, progeny virions are not released from sialic acids on the plasma membrane and found to be aggregated on the cell surface17,18. Further, it is known that this activity contributes to prevention of successive super-infection of infected cells19.
Viruses are released as cell-free virions from an infected cell and become infected to distant cells and tissues. In contrast, the virus transmission mechanism from an infected cell to adjacent cells without viral diffusion into the extracellular environment, termed cell-to-cell transmission, has been reported in several viruses20,21. In general, influenza virus becomes infected from an infected cell to uninfected cells as cell-free virions. Previously, we reported that cell-to-cell transmission of influenza virus also occurs in the presence of oseltamivir which is a potent inhibitor of sialidase activity of NA22,23,24. Since progeny virions are enriched on the plasma membrane of an infected cell in the presence of oseltamivir, it is assumed that viruses become infected to adjacent cells at high multiplicity of infection via cell-to-cell transmission.
Here, we showed that temperature-sensitive (ts) mutations remain in progeny viruses even at non-permissive temperature by co-infection in the presence of oseltamivir. This is possibly due to a multiplex infection through the cell-to-cell transmission by the addition of oseltamivir. Further, Next-Generation sequencing analyses revealed that spontaneous mutations introduced by error-prone replication were accumulated in the virus population by oseltamivir treatment. In conclusion, we propose that oseltamivir expands the virus quasispecies via cell-to-cell transmission and cell-to-cell transmission may contribute to the evolution of influenza virus.
Results
Survival of defective variants by oseltamivir treatment
Virus quasispecies are diversified by the error-prone virus genome replication. Defective mutations are generated, but defective viruses can survive in the virus quasispecies population through incidental infection of wild-type virus or viruses containing different type of mutation(s) as helper virus. Thus, it is suggested that high multiplicity of infection is important for the expansion of virus quasispecies. Recently, we found that progeny influenza virions become infected to the adjacent cells via cell-to-cell transmission in the presence of oseltamivir possibly with high multiplicity of infection23. Thus, we hypothesized that oseltamivir maintains defective variants in virus quasispecies population by co-infection.
To examine the hypothesis, we carried out co-infection experiments using temperature-sensitive (ts) mutant viruses, ts1 and ts53. The viral transcription of ts1 is defective at non-permissive temperature due to a mutational change in PB2 polymerase subunit at the amino acid position of 417 from Asp to Asn25,26. A point mutation causing the change from Leu to Pro at the amino acid position of 226 in ts53 PA polymerase subunit results in the defective virus genome replication at non-permissive temperature27,28,29. Since these point mutations are located in different virus genome segments, wild-type virus can be produced by reassortment between ts1 and ts53 during co-infection. To perform co-infection experiments using ts1 and ts53 efficiently, 0.1% confluent Madin-Darby canine kidney (MDCK) cells were co-infected with ts1 and ts53 at each multiplicity of infection (MOI) of 5 (Fig. 1a). In order to facilitate the infection of progeny viruses from co-infected cells to adjacent uninfected cells, fresh MDCK cells were overlaid onto co-infected cells confluently after virus adsorption, followed by incubation at either permissive (34°C) or non-permissive temperature (39.5°C) in the absence or presence of 50 μg/ml of oseltamivir. Oseltamivir at the concentration of 50 μg/ml completely blocks the release of progeny influenza viruses23. The culture medium including progeny virions was collected at 60 hours post infection (hpi). The viral titers of wild-type and ts mutant viruses were determined by plaque assays at permissive and non-permissive temperatures (Fig. 1a). It is reported that there are several mutations in NA conferring resistance to oseltamivir30, but both of ts mutant viruses did not have such mutations (Supplementary Fig. 1). The virus titer determined by plaque assays at 34°C indicates those including ts mutant viruses and wild-type virus, while the virus titer determined at 39.5°C indicates that for wild-type virus alone. Therefore, the ratio of virus titers between 34°C and 39.5°C means a population rate of ts mutant viruses. During infection with single ts mutant, cells that were infected with ts mutant and incubated at 34°C and 39.5°C did not produce any wild-type virus that could grow at 39.5°C in plaque assay (Table 1). Co-infection with ts1 and ts53 at permissive temperature without oseltamivir produced 1.2 × 105 plaque forming unit (PFU)/ml of wild-type virus possibly due to segment reassortment. The virus titer determined at 34°C was 1.3 × 106 PFU/ml including both ts mutant viruses and wild-type virus. Thus, the population rate of ts virus was calculated to be 91% (Table 1 and Fig. 1b). At non-permissive temperature, co-infection with ts1 and ts53 without oseltamivir produced 1.6 × 105 PFU/ml of wild-type virus. The virus titer determined at 34°C was 1.5 × 105 PFU/ml including ts mutant viruses and wild-type virus, suggesting that the production of ts mutant viruses hardly occurs in the absence of oseltamivir. On the other hand, co-infection with ts1 and ts53 in the presence of oseltamivir at non-permissive temperature produced 6.9 × 103 PFU/ml of wild-type virus, while the virus titer determined at 34°C including ts mutant viruses and wild-type virus was 4.3 × 104 PFU/ml. Thus, it is calculated that the population rate of ts mutant was 83% by co-infection with ts1 and ts53 with oseltamivir treatment even cultured at non-permissive temperature.
To further confirm this, total RNA was purified from infected cells at 40 hpi and cDNA fragments amplified from segment 3 viral RNA were digested by Stu I as reported previously23. ts53 virus has a substitution mutation from U to C at the nucleotide position of 701 in segment 3 encoding PA, while the sequence of segment 3 of ts1 virus is the same as that of wild-type virus. The digested DNA fragments containing 220 and 199 base pairs were derived from ts53 and wild-type viruses, respectively. As expected, the virus genome derived from ts53 was clearly found even at non-permissive temperature in the presence of oseltamivir (Fig. 1c), suggesting that defective mutations are maintained in the virus population produced in the presence of oseltamivir.
Influenza virus particles are enriched on the cell surface by inhibiting the virus release from the infected cells with oseltamivir17,18. These accumulated progeny virions may become infected to adjacent cells via cell-to-cell transmission23. To support this, we carried out transmission electron microscopic analyses with or without 50 μg/ml oseltamivir. As reported previously31, large clusters of progeny virions were attached to the apical plasma membrane by oseltamivir treatment (Fig. 2a). Further, we found that, in the presence of oseltamivir, a significant amount of the progeny virions accumulated in intercellular space (Fig. 2b). Thus, it is possible that accumulated progeny virions present in intercellular space become infected to adjacent cells via cell-to-cell transmission in the presence of oseltamivir. Taken these results together, progeny virions containing defective virus genomes could be rescued by co-infection with helper viruses at the high multiplicity of infection via cell-to-cell transmission.
Diversity of virus quasispecies in the presence of oseltamivir
The fidelity of the influenza viral RNA-dependent RNA polymerase is quite low and therefore generates virus quasispecies32,33,34. In the presence of oseltamivir, ts mutant viruses were maintained in the virus quasispecies population via cell-to-cell transmission (Fig. 1). Based on this, we hypothesized that spontaneous mutations introduced by the error-prone replication are accumulated in virus quasispecies population generated via cell-to-cell transmission in the presence of oseltamivir. To address this, serial virus passages were carried out in the presence or absence of oseltamivir and mutations were detected by Next-Generation sequencing (NGS). We generated a recombinant WSN/33 virus by a plasmid-driven reverse genetics method35 to prepare a monoclonal parent strain as passage 0 (P0) virus. MDCK cells infected with P0 virus were cultured in the absence or presence of 50 μg/ml of oseltamivir. When cytopathic effects (CPE) were observed, the culture supernatant containing P1 virus was collected and subjected to the second round infection. These processes were serially repeated 12 times (Fig. 3a). The mutation related with the resistance to oseltamivir was not found in P12 virus which was treated with oseltamivir (Supplementary Fig. 1). After reverse transcription of viral RNA purified from P1, P4, P8 and P12 viruses, cDNAs of segment 8 and segment 5 between the nucleotide positions of 41 to 386 and 217 to 552, respectively were amplified by PCR. To evaluate the intrinsic error rate associated with NGS, segment 8 cDNA was also amplified by PCR using plasmid as a template and subjected to NGS. The error rate of NGS was 3.4 × 10−5/nt. Thus, we subtracted the error rate of NGS from the mutation rate obtained from each sample. Without oseltamivir treatment, the number of mutation in virus quasispecies population was not changed along with serial passages. In contrast, the mutation rates of both segment 8 and segment 5 were clearly increased in a passage-dependent manner by the addition of oseltamivir (Fig. 3b). These results indicated that the spontaneous mutations introduced by the error-prone replication are accumulated in virus quasispecies population in the presence of oseltamivir. Nucleotide substitution results in missense, silent, or nonsense mutation. Without oseltamivir treatment, the number of missense, silent and nonsense mutations was not changed significantly. On the other hand, the number of missense mutation of P8 and P12 virus in segment 8 was clearly increased in the presence of oseltamivir (Fig. 3c). In the case of segment 5, the number of silent mutation was significantly increased, but the number of missense mutation was not increased dramatically. Collectively, it is considered that the mutations introduced by the error-prone replication are propagated in virus quasispecies in the presence of oseltamivir.
Discussion
Here, we demonstrated that oseltamivir expands the influenza virus quasispecies through the cell-to-cell transmission. By the addition of oseltamivir, the number of missense mutation in segment 8 was increased in a passage-dependent manner. The number of missense mutation in segment 5 was not changed significantly, whereas silent mutation in segment 5 was increased (Fig. 3c). It is well known that NS1 encoded by segment 8 is tolerant of amino acid changes, while NP encoded by segment 5 is strongly restricted36. NS1 inhibits the cellular gene expression and prevents the activation of interferon system37. Further, NS1 selectively enhances the translation of viral mRNA and may regulate the synthesis of viral RNA indirectly37. Although these functions of NS1 contribute to effective virus production, NS1 is not necessary for virus production38, suggesting that the competition between functional and dysfunctional NS1, if any, is not completely a serious problem. However, NP plays a key role for the virus genome replication and necessary for infectious virus production39. It is possible that the competition between functional and defective NP possibly as dominant negative mutant and/or decoy could give negative effect on the virus replication. Thus, missense mutations might not be accumulated in segment 5.
In the presence of oseltamivir, progeny influenza virus virions were found not only on apical plasma membrane but also in intercellular space (Fig. 2). It is generally thought that the budding of influenza virus as a cell-free virion occurs only from the apical surface40, since HA and NA glycoproteins are intrinsically transported to the apical plasma membrane41,42. Thus, it is assumed that the virions accumulated on apical plasma membrane might be translocated into intercellular space by trafficking of apical recycling endosomes to the lateral plasma membrane43. It is possible that the intercellular space is a tight structure so as to be a barrier to fluid between apical aqueous environment and intercellular space. Thus, it is speculated that virions accumulated in intercellular space become infected to adjacent cells due to decrease in concentration of oseltamivir in intercellular space.
Error-prone replication anticipates the existence of an error threshold for the maintenance of genetic information. Increase of the average error frequency above a critical threshold during virus genome replication could cause the loss of genetic information resulting in the extinction of virus population, called error catastrophe44. The existence of a threshold for the mutation rate of virus replication has been reported. Above the 6.4 times increase in mutation rate of foot-and-mouth disease virus leads to viral extinction45. Four times increase in polio virus strongly decreases viral infectivity46. We demonstrated that the number of mutation in quasispecies of influenza virus population in the presence of oseltamivir increased gradually and reached around twice at P12 virus compared with that at P1. Taken these previous reports and our study together, it is likely that the cell-to-cell transmission in the presence of oseltamivir provides influenza virus with advantage in evolution such as a chance to generate anti-oseltamivir viruses.
It has been reported that the cell-to-cell transmission provides viruses with advantages. Vaccinia virus induces a blocking mechanism of super-infection and thereby become infected to adjacent uninfected cells rapidly47. Viral spread via tight cell-cell contacts allows many viruses to escape from neutralizing antibodies thus leading to immune evasion48,49,50. TRIM5α, that is viral restriction factor and effectively inhibits cell-free retroviruses, are less effective to cell-to-cell transmission51. Our findings propose a new idea that the cell-to-cell transmission results in expansion of virus quasispecies and may contribute to evolution and adaptation to new environments.
Methods
Cells and viruses
MDCK cells were maintained in minimal essential medium (MEM) (Sigma) containing 10% fetal bovine serum. Influenza virus A/WSN/33 and temperature sensitive mutants (ts1 and ts53)26,27 were used after single-plaque isolation. MDCK cells were infected with influenza virus A/WSN/33 or ts mutants at MOI of 0.01 PFU/cell and incubated at 37°C and 34°C, respectively. After incubation for 48 h, the culture fluid was harvested and centrifuged at 1,700 × g for 10 min. The virus suspension was stored at −80°C until use.
Co-infection
To examine the transmission of influenza virus from individual co-infected cells to adjacent cells, we carried out co-infection of ts1 and ts53. ts1 and ts53 are defective at non-permissive temperature due to a mutation in segment 1 and segment 3, respectively. The segmented genome of influenza virus provides the opportunity to produce reassortant viruses during co-infection in a cell. Since ts mutations of ts1 and ts53 are located in different virus genome segments, wild-type virus was produced by reassortment between ts1 and ts53. For efficient co-infection of ts1 and ts53, MDCK cells at 0.1% confluency were co-infected with ts1 and ts53 at each MOI of 5. After virus adsorption at 37°C for 1 hour, cells were washed with serum-free MEM and fresh MDCK cells were overlaid onto co-infected cells confluently to examine the transmission of progeny viruses from co-infected cells to adjacent cells. After incubation for 6 hours at either permissive (34°C) or non-permissive temperature (39.5°C) in the absence or presence of 50 μg/ml of oseltamivir phosphate, cells were washed with serum-free MEM. Then, maintenance medium (MEM containing vitamins and 0.1% BSA) was added with or without 50 μg/ml of oseltamivir phosphate and cultured at either 34°C or 39.5°C. At 60 hpi, the culture supernatant was collected and then its virus titer was determined by plaque assays under both 34°C and 39.5°C. Viruses grown in the presence of oseltamivir were harvested from the cell surface by treatment with 30 mU/ml of bacterial NA derived from Clostridiun perfringens (SIGMA).
RT-PCR
ts53 virus has a substitution mutation from U to C at the nucleotide position of 701 in segment 3 encoding PA, while the sequence of segment 3 of ts1 virus is the same as that of wild-type virus. To discriminate the genome of ts1 (wild-type) and that of ts53, total RNA was reverse-transcribed by SuperScript III (Invitrogen) with PA-895-rev (5′-TTAATTTTAAGGCATCCATCAGCAGG-3′), which is complementary to positive-sense RNA of the segment 3. The cDNA was amplified by PCR using primers, PA-895-rev and PA-695-cut (5′-TCTCCCGCCAAACTTCTCAGGCC-3′) partially corresponding to positive-sense RNA of segment 3 between nucleotide sequence positions 678 to 700 except for nucleotide positions 696 and 697. Since segment 3 of ts53 has a substitution mutation from U to C at the nucleotide position of 701, PCR products derived from wild-type could be digested by Stu I but not that from ts53. After PCR reactions, PCR products were digested with Stu I and separated on native-PAGE. Large and small fragments derived from ts53 and wild-type viruses were 220 and 199 base pairs, respectively23. DNA was stained with GelRed (BIOTIUM) and visualized by UV illumination.
Transmission electron microscope (TEM)
MDCK cells were infected with virus at MOI of 10 and cultured in the absence or presence of 50 μg/ml of oseltamivir phosphate. After incubation at 37°C for 16 h, cells were subsequently fixed with 2.5% of glutaraldehyde. After further fixation with 1% OsO4 for 1 h, sequential dehydrations with ethanol in a stepwise manner were carried out followed by propylene oxide treatment and embedded in Poly/Bed 812 (Polysciences). Ultrathin sections were examined with a JEM-1300 (JEOL) operated at 80 kV.
Next-generation sequencing (NGS)
Amplicon generation and NGS were carried out as previously reported52. Briefly, viral RNA was extracted using Mag/Extractor-RNA- (TOYOBO). Total RNA was reverse-transcribed by reverse transcriptase (TOYOBO) with oligonucleotide primers (5′-AGCAAAAGCAGGGTAGATAA-3′) and (5′-AGCAAAAGCAGGGTGACAAA-3′), which are complementary to nucleotide sequences between position 1 to 20 negative-sense RNAs of segment 5 and 8, respectively. The cDNA was amplified by PCR using fusion primers including multiplex identifier tag (MID) and adaptor for 454 sequencing, (5′-CGTATCGCCTCCCTCGCGCCATCAGTACTGAGCTACAGAACAGCTTAACAATAGA-3′) and (5′-CTATGCGCCTTGCCAGCCCGCTCAGTACTGAGCTAACCCTGCATCAGTGAGCACA-3′) corresponding to segment 5 between nucleotide sequence positions 217 to 236 and 533 to 552, respectively. To amplify segment 8 cDNA, primers, (5′-CGTATCGCCTCCCTCGCGCCATCAGAGCACTGTAGTGTGTCAAGCTTTCAGGTAG-3′) and (5′-CTATGCGCCTTGCCAGCCCGCTCAGAGCACTGTAGGTCCATTCTGATACAAAGAGG-3′) corresponding to segment 8 between nucleotide sequence positions 41 to 60 and 366 to 386, respectively were used. PCR products were purified by agarose gel using Fast Gene Gel Extraction Kit (NIPPON Genetics). Amplicons were subjected to ultra-deep pyrosequencing using GsJunior (454 Life Sciences, Roche).
Data analysis
The output from the GSJunior includes sequence results (FASTA) and quality score for every sequence position in a read. It is known that average quality score of a read is inversely proportional to the number of errors in that read53. To suppress the error associated with NGS, we eliminated the reads including quality score below 27 at one sequence position. The reads which were passed through quality filter were aligned by ClustalW as previously reported54 and the number of mutation in each sequence position was counted.
References
Domingo, E. & Holland, J. J. RNA virus mutations and fitness for survival. Annu Rev Microbiol 51, 151–178, 10.1146/annurev.micro.51.1.151 (1997).
Drake, J. W. & Holland, J. J. Mutation rates among RNA viruses. Proc Natl Acad Sci U S A 96, 13910–13913 (1999).
Holland, J. et al. Rapid evolution of RNA genomes. Science 215, 1577–1585 (1982).
Coffin, J. M. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 267, 483–489 (1995).
Havlir, D. V., Eastman, S., Gamst, A. & Richman, D. D. Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients. J Virol 70, 7894–7899 (1996).
Hurt, A. C. & Barr, I. G. Influenza viruses with reduced sensitivity to the neuraminidase inhibitor drugs in untreated young children. Commun Dis Intell Q Rep 32, 57–62 (2008).
Lech, W. J. et al. In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects. J Virol 70, 2038–2043 (1996).
Najera, I. et al. Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J Virol 69, 23–31 (1995).
Webster, R. G., Laver, W. G., Air, G. M. & Schild, G. C. Molecular mechanisms of variation in influenza viruses. Nature 296, 115–121 (1982).
Forns, X., Purcell, R. H. & Bukh, J. Quasispecies in viral persistence and pathogenesis of hepatitis C virus. Trends Microbiol 7, 402–410, S0966-842X(99)01590-5 (1999).
Weiner, A. et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci U S A 92, 2755–2759 (1995).
Pfeiffer, J. K. & Kirkegaard, K. Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog 1, e11, 10.1371/journal.ppat.0010011 (2005).
Vignuzzi, M., Stone, J. K., Arnold, J. J., Cameron, C. E. & Andino, R. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439, 344–348, nature04388 (2006).
Biebricher, C. K. & Eigen, M. The error threshold. Virus Res 107, 117–127, S0168-1702(04)00384-3 (2005).
Wiley, D. C. & Skehel, J. J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56, 365–394, 10.1146/annurev.bi.56.070187.002053 (1987).
Air, G. M. & Laver, W. G. The neuraminidase of influenza virus. Proteins 6, 341–356, 10.1002/prot.340060402 (1989).
Palese, P., Tobita, K., Ueda, M. & Compans, R. W. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61, 397–410 (1974).
Shibata, S. et al. Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase. J Virol 67, 3264–3273 (1993).
Huang, I. C. et al. Influenza A virus neuraminidase limits viral superinfection. J Virol 82, 4834–4843, JVI.00079-08 (2008).
Sattentau, Q. Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol 6, 815–826, 10.1038/nrmicro1972 (2008).
Zhong, P., Agosto, L. M., Munro, J. B. & Mothes, W. Cell-to-cell transmission of viruses. Curr Opin Virol 3, 44–50, S1879-6257(12)00183-6 (2013).
Lew, W., Chen, X. & Kim, C. U. Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor. Curr Med Chem 7, 663–672 (2000).
Mori, K., Haruyama, T. & Nagata, K. Tamiflu-resistant but HA-mediated cell-to-cell transmission through apical membranes of cell-associated influenza viruses. PLoS One 6, e28178, 10.1371/journal.pone. (2011).
Nedyalkova, M. S., Hayden, F. G., Webster, R. G. & Gubareva, L. V. Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NA. J Infect Dis 185, 591–598, JID011075 (2002).
Sugiura, A., Tobita, K. & Kilbourne, E. D. Isolation and preliminary characterization of temperature-sensitive mutants of influenza virus. J Virol 10, 639–647 (1972).
Yamanaka, K. et al. Characterization of a temperature-sensitive mutant in the RNA polymerase PB2 subunit gene of influenza A/WSN/33 virus. Arch Virol 114, 65–73 (1990).
Kawaguchi, A., Naito, T. & Nagata, K. Involvement of influenza virus PA subunit in assembly of functional RNA polymerase complexes. J Virol 79, 732–744, 10.1128/JVI.79.2.732-744.2005 (2005).
Krug, R. M., Ueda, M. & Palese, P. Temperature-sensitive mutants of influenza WSN virus defective in virus-specific RNA synthesis. J Virol 16, 790–796 (1975).
Sugiura, A., Ueda, M., Tobita, K. & Enomoto, C. Further isolation and characterization of temperature-sensitive mutants of influenza virus. Virology 65, 363–373 (1975).
Abed, Y., Baz, M. & Boivin, G. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds. Antivir Ther 11, 971–976 (2006).
Liu, C., Eichelberger, M. C., Compans, R. W. & Air, G. M. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J Virol 69, 1099–1106 (1995).
Aggarwal, S., Bradel-Tretheway, B., Takimoto, T., Dewhurst, S. & Kim, B. Biochemical characterization of enzyme fidelity of influenza A virus RNA polymerase complex. PLoS One 5, e10372, 10.1371/journal.pone.0010372 (2010).
Nobusawa, E. & Sato, K. Comparison of the mutation rates of human influenza A and B viruses. J Virol 80, 3675–3678, 80/7/3675 (2006).
Parvin, J. D., Moscona, A., Pan, W. T., Leider, J. M. & Palese, P. Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1. J Virol 59, 377–383 (1986).
Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96, 9345–9350 (1999).
Heiny, A. T. et al. Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets. PLoS One 2, e1190, 10.1371/journal.pone.0001190 (2007).
Marc, D. Influenza virus non-structural protein NS1: interferon-antagonism and beyond. J Gen Virol 95, 2594–2611, 10.1099/vir.0.069542-0 (2014).
Garcia-Sastre, A. et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252, 324–330, S0042682298995083 (1998).
Nagata, K., Kawaguchi, A. & Naito, T. Host factors for replication and transcription of the influenza virus genome. Rev. Med. Virol. 18, 247–260, 10.1002/rmv.575 (2008).
Nayak, D. P., Hui, E. K. & Barman, S. Assembly and budding of influenza virus. Virus Research 106, 147–165, 10.1016/j.virusres.2004.08.012 (2004).
Cresawn, K. O. et al. Differential involvement of endocytic compartments in the biosynthetic traffic of apical proteins. Embo J 26, 3737–3748, 10.1038/sj.emboj.7601813 (2007).
Guerriero, C. J., Lai, Y. & Weisz, O. A. Differential sorting and Golgi export requirements for raft-associated and raft-independent apical proteins along the biosynthetic pathway. J Biol Chem 283, 18040–18047, 10.1074/jbc.M802048200 (2008).
Stenmark, H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 10, 513–525, nrm2728 (2009).
Eigen, M. Error catastrophe and antiviral strategy. Proc Natl Acad Sci U S A 99, 13374–13376, 10.1073/pnas.212514799 (2002).
Sierra, S., Davila, M., Lowenstein, P. R. & Domingo, E. Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J Virol 74, 8316–8323 (2000).
Crotty, S., Cameron, C. E. & Andino, R. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A 98, 6895–6900, 10.1073/pnas.111085598 (2001).
Doceul, V., Hollinshead, M., van der Linden, L. & Smith, G. L. Repulsion of superinfecting virions: a mechanism for rapid virus spread. Science 327, 873–876, 10.1126/science.1183173 (2010).
Abela, I. A. et al. Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies. PLoS Pathog 8, e1002634, 10.1371/journal.ppat.1002634 (2012).
Gupta, P., Balachandran, R., Ho, M., Enrico, A. & Rinaldo, C. Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody. J Virol 63, 2361–2365 (1989).
Merz, D. C., Scheid, A. & Choppin, P. W. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med 151, 275–288 (1980).
Richardson, M. W. et al. Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha. J Virol 82, 11117–11128, JVI.01046-08 (2008).
Simen, B. B. et al. An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing. J Virol Methods 204, 31–37, 10.1016/j.jviromet.2014.04.007 (2014).
Huse, S. M., Huber, J. A., Morrison, H. G., Sogin, M. L. & Welch, D. M. Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol 8, R143, gb-2007-8-7-r143 (2007).
Thompson, J. D., Higgins, D. G. & Gibson, T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673–4680 (1994).
Acknowledgements
We thank J. Sakamoto and M. Kobayashi (University of tsukuba) for their assistance in operation of transmission electron microscopy. We also thank A. Shimono, T. Shimazaki and K. Matsuno (Gene Research Center, University of Tsukuba) for their support for operation of Next-Generation sequencer. The operation of Next-generation sequencer was also supported by Japan Advanced Plant Science Network. We are grateful to M. N. Asaka and T. Sekiya (University of Tsukuba) for valuable discussion. This research was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K.N. and A.K.).
Author information
Authors and Affiliations
Contributions
K.T.M., A.K. and K.N. designed research. K.T.M. performed experimental works. K.T.M. and R.L.O. analyzed data. K.T.M., K.S.M., A.K. and K.N. wrote the manuscript.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Electronic supplementary material
Supplementary Information
Supplementary Information
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder in order to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Mori, K., Murano, K., Ohniwa, R. et al. Oseltamivir Expands Quasispecies of Influenza Virus through Cell-to-cell Transmission. Sci Rep 5, 9163 (2015). https://doi.org/10.1038/srep09163
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep09163
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.